Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Ruxolitinib combined with P-gemox in adult patients with newly diagnosed aggressive natural killer cell leukemia

Xueying Yang, Xin Huang, Jiejing Qian, Xingnong Ye, Gaixiang Xu, Wenjuan Yu, Mixue Xie, Hongyan Tong, De Zhou

Blood (2025) 146 (Supplement 1): 7149.

https://doi.org/10.1182/blood-2025-7149

Published: 2025

Journal Articles

A novel strategy to circumvent venetoclax resistance in relapsed/refractory Acute Myeloid Leukemia

Huafeng Wang, Yile Zhou, Xiang Zhang, Liping Mao, Xia Li, Xingnong Ye, Mixue Xie, De Zhou, Xiudi Yang, Jian Huang, Wenjuan Yu, Juying Wei, Min Yang, Yinjun Lou, Yanhong Tong, Jie Jin

Blood (2025) 146 (Supplement 1): 3464.

https://doi.org/10.1182/blood-2025-3464

Published: 2025

Journal Articles

Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China

De Zhou, Xianbo Huang, Lixia Zhu, Xuelian Hu, Xiudi Yang, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Jingjing Zhu, Shuqi Zhao, Wanzhuo Xie, Hongyan Tong, Jie Jin, Xiujin Ye

Blood (2025) 146 (3): 318–327.

https://doi.org/10.1182/blood.2024026139

Published: 2025

Includes: Supplemental data

Journal Articles

Combination of Decitabine and Etoposide Is Highly Effective in Treating p53-Mutated MDS/AML Via Activating Notch Signaling

Jiexian Ma, Shunrong Sun, Min Wu, Xinyu Zuo, Mixue Xie, Xiaoqin Wang, Xiu-Jin Ye, Shuhong Shen, Yanhui Xie

Blood (2023) 142 (Supplement 1): 4131.

https://doi.org/10.1182/blood-2023-184355

Published: 2023

Journal Articles

Flumatinib Versus Imatinib As a Frontline Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase: A Propensity Score Matching Study from Real-World Data

Mixue Xie, Dan Li, Jie Jin, Hongyan Tong

Blood (2023) 142 (Supplement 1): 6359.

https://doi.org/10.1182/blood-2023-174679

Published: 2023

Journal Articles

Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial

De Zhou, Xianbo Huang, Xueying Li, Lixia Zhu, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Xiudi Yang, Jianai Sun, Li Li, Wanzhuo Xie, Hongyan Tong, Jie Jin, Honghu Zhu, Xiujin Ye

Blood (2022) 140 (Supplement 1): 2620–2621.

https://doi.org/10.1182/blood-2022-164496

Published: 2022

Journal Articles

Interim Results of a Phase II Study of Dasatinib and Prednisone As an Oral, Chemo-Free Induction and Consolidation Regimen for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Mixue Xie, Ying Lu, Guifang Ouyang, Liming Zhang, Huixian Hu, Ting Shi, Xueying Li, Xiujing Ye, Jie Jin, Hong-Hu Zhu

Blood (2021) 138 (Supplement 1): 4402.

https://doi.org/10.1182/blood-2021-152554

Published: 2021

Journal Articles

Ruxolitinib Combined with Dexamethasone in Adult Patients with Secondary HLH：a Single-Centre Pilot Trial

De Zhou, Xianbo Huang, Mixue Xie, Hong-Hu Zhu, Jie Jin, Xiujing Ye

Blood (2021) 138 (Supplement 1): 198.

https://doi.org/10.1182/blood-2021-152921

Published: 2021

Journal Articles

Megakaryocyte Morphological Classification Based Predictive Model for Steroid Sensitivity in Primary Immune Thrombocytopenia

Mixue Xie, Jingjing Zhu, Yanlong Zheng, Xueying Li, Xianbo Huang, MD PhD, Xiujin Ye, MD PhD

Blood (2019) 134 (Supplement_1): 4911.

https://doi.org/10.1182/blood-2019-123627

Published: 2019

Journal Articles

Akt2 Mediates Glucocorticoid Resistance in Acute Lymphoblastic Leukemia through FoxO3a/Bim Axis and Serves As a Direct Target for Resistance Reversal

Mixue Xie, Yanhui Xie, PhD, Apeng Yang, MD, Jiexian Ma, MD, Min Wu, Youxin Jin, PhD

Blood (2018) 132 (Supplement 1): 3955.

https://doi.org/10.1182/blood-2018-99-110496

Published: 2018

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Ruxolitinib combined with P-gemox in adult patients with newly diagnosed aggressive natural killer cell leukemia

A novel strategy to circumvent venetoclax resistance in relapsed/refractory Acute Myeloid Leukemia

Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China

Combination of Decitabine and Etoposide Is Highly Effective in Treating p53-Mutated MDS/AML Via Activating Notch Signaling

Flumatinib Versus Imatinib As a Frontline Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase: A Propensity Score Matching Study from Real-World Data

Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial

Interim Results of a Phase II Study of Dasatinib and Prednisone As an Oral, Chemo-Free Induction and Consolidation Regimen for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Ruxolitinib Combined with Dexamethasone in Adult Patients with Secondary HLH：a Single-Centre Pilot Trial

Megakaryocyte Morphological Classification Based Predictive Model for Steroid Sensitivity in Primary Immune Thrombocytopenia

Akt2 Mediates Glucocorticoid Resistance in Acute Lymphoblastic Leukemia through FoxO3a/Bim Axis and Serves As a Direct Target for Resistance Reversal

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only